FDA to Unveil Covid Shot Policy
Digest more
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Mexico halts Brazilian poultry imports after a bird flu outbreak, the U.S. FDA conditionally approves Novavax's COVID vaccine, and allows the first Alzheimer's blood test. Meanwhile, Assura is outbid by PHP in a takeover,
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump administration has introduced uncertainty into the annual process for green-lighting updated coronavirus shots traditionally offered in the fall.
A new report says Health and Human Services Secretary Robert F. Kennedy Jr. will roll back current CDC guidance on COVID vaccinations for pregnant women and children.
A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators want to see data on whether the new vaccine protects people from getting sick.